Neutra Corp. (NTRR)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0001 (-50.00%)
Mar 3, 2026, 4:00 PM EST

Revenue by Segment

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Jan '24 Jan '23 Jan '22 Jan '21 Jan '20 Jan '19 Jan '18 Jan '17 Jan '16 Jan '15
Pharmaceuticals
39.53K68.00K92.01K9.69K6.40K
Pharmaceuticals Growth
-41.86%-26.10%849.87%51.48%-
Total
39.53K68.00K92.01K9.69K6.40K
Total Growth
-41.86%-26.10%849.87%51.48%-

Revenue by Geography

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Jan '24 Jan '23 Jan '22 Jan '21 Jan '20 Jan '19 Jan '18 Jan '17 Jan '16 Jan '15
United States
39.53K68.00K92.01K9.69K6.40K
United States Growth
-41.86%-26.10%849.87%51.48%-
Total
39.53K68.00K92.01K9.69K6.40K
Total Growth
-41.86%-26.10%849.87%51.48%-
Source: S&P Global Market Intelligence.